1. Home
  2. WABC vs TSHA Comparison

WABC vs TSHA Comparison

Compare WABC & TSHA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Westamerica Bancorporation

WABC

Westamerica Bancorporation

N/A

Current Price

$58.75

Market Cap

1.4B

Sector

Finance

ML Signal

N/A

Logo Taysha Gene Therapies Inc.

TSHA

Taysha Gene Therapies Inc.

N/A

Current Price

$4.76

Market Cap

1.7B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
WABC
TSHA
Founded
1972
2019
Country
United States
United States
Employees
627
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.4B
1.7B
IPO Year
1994
2020

Fundamental Metrics

Financial Performance
Metric
WABC
TSHA
Price
$58.75
$4.76
Analyst Decision
Hold
Strong Buy
Analyst Count
2
13
Target Price
★ $64.00
$13.00
AVG Volume (30 Days)
171.7K
★ 2.8M
Earning Date
10-15-2026
11-03-2026
Dividend Yield
★ 3.29%
N/A
EPS Growth
N/A
★ 5.56
EPS
★ 3.40
N/A
Revenue
N/A
★ $9,773,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$1,023.00
P/E Ratio
$17.19
★ N/A
Revenue Growth
N/A
★ 17.28
52 Week Low
$44.93
$3.69
52 Week High
$63.61
$7.30

Technical Indicators

Market Signals
Indicator
WABC
TSHA
Relative Strength Index (RSI) 39.11 38.99
Support Level $55.80 $4.37
Resistance Level $60.49 $5.07
Average True Range (ATR) 1.21 0.24
MACD -0.21 0.01
Stochastic Oscillator 0.00 37.78

Price Performance

Historical Comparison
WABC
TSHA

About WABC Westamerica Bancorporation

Westamerica Bancorp provides a full range of banking services to individual and commercial customers in Northern and Central California through its subsidiary bank. The Bank is a California-chartered commercial bank whose deposits are insured by the Federal Deposit Insurance Corporation (the FDIC) up to applicable limits. The principal communities served are located in Northern and Central California, from Mendocino, Lake and Nevada Counties in the north to Kern County in the south. The Company's strategic focus is on the banking needs of small businesses.

About TSHA Taysha Gene Therapies Inc.

Taysha Gene Therapies Inc is a clinical-stage biotechnology company focused on advancing AAV-based gene therapies for the treatment of severe monogenic diseases of the central nervous system, or CNS. The company's clinical program TSHA-102 is in development for the treatment of Rett syndrome, a rare neurodevelopmental disorder with no approved disease-modifying therapies that address the genetic root cause of the disease. The Company views its operations and manages its business as a single operating segment, the gene therapy segment, which is the business of developing AAV-based gene therapies for the treatment of rare monogenic diseases of the central nervous system.

Share on Social Networks: